High heterogeneity in methods used for the laboratory confirmation of pertussis diagnosis among European countries, 2010: Integration of epidemiological and laboratory surveillance must include standardisation of methodologies and quality assurance

Eurosurveillance

Volumn 17, Issue 32, 2012, Pages

  He, Q ^a   Barkoff, A M ^a   Mertsola, J ^b   Glismann, S ^c   Bacci, S ^c   He, Qiushui ^d   Mertsola, Jussi ^d   Wirsing von König, Carl Heinz ^d   Riffelmann, Marion ^d   Guiso, Nicole ^d   Guillot, Sophie ^d   Hallander, Hans ^d   Advani, Abdolreza ^d   Mooi, Frits R ^d   Berbers, Guy ^d   Lutyńska, Anna ^d   Krogfelt, Karen ^d   Dalby, Tine ^d   Fry, Norman ^d   Xing, Dorothy ^d   Locht, Camille ^d   Hot, David ^d   Ausiello, Clara Maria ^d   Stefanelli, Paola ^d   Carollo, Maria ^d   Sandven, Per ^d   Storsaeter, Jann ^d   Mittermayer, Helmut ^d   Kerschner, Heidrun ^d   Pierard, Denis ^d   Huygen, Kris ^d   Dufaux, Maryse Fauville ^d   Panaiotov, Stefan ^d   Tomova, Iskra ^d   Zarvou, Marios ^d   Hadjianastassiou, Chrystalla ^d   Zavadilova, Jana ^d   Njunkova, Natalja ^d   von König, Carl Heinz Wirsing ^d   Giannaki Psinakis, Maria ^d   Bognár, Csaba ^d   Hauksdóttir, Guðrún Svanborg ^d   O’Sullivan, Niamh ^d   Galajeva, Jelena ^d   Storoženko, Jelena ^d   Dauksiene, Snieguole ^d   Reichert, Paul ^d   Haider, Julie ^d   Zasada, Aleksandra Anna ^d   Ungureanu, Vasilica ^d   Klement, Cyril ^d   Paragi, Metka ^d   more..

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c STATENS SERUM INSTITUT   (Denmark)

^d NONE   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PERTUSSIS TOXIN;

ARTICLE; BACTERIUM CULTURE; BORDETELLA PERTUSSIS; DISEASE SEVERITY; DISEASE SURVEILLANCE; ENZYME LINKED IMMUNOSORBENT ASSAY; EUROPE; GENE INSERTION SEQUENCE; GEOGRAPHIC DISTRIBUTION; HUMAN; LABORATORY DIAGNOSIS; PERTUSSIS; POLYMERASE CHAIN REACTION; QUALITY CONTROL; QUESTIONNAIRE; REFERENCE VALUE; SENSITIVITY AND SPECIFICITY; SERODIAGNOSIS; STANDARDIZATION;

EID: 84866432374     PISSN: 1025496X     EISSN: 15607917     Source Type: Journal    
DOI: 10.2807/ese.17.32.20239-en     Document Type: Article

References (37)

1. Mattoo S, Cherry JD. Molecular pathogenesis, epidemiology, and clinical manifestations of respiratory infections due to Bordetella pertussis and other Bordetella subspecies. Clin Microbiol Rev. 2005;18:362-82.
2. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet. 2006;367(9526):1926-36.
3. He Q, Mertsola J. Factors contributing to pertussis resurgence. Future Microbiol. 2008;3(3):329-39.
4. Mooi FR. Bordetella pertussis and vaccination: the persistence of a genetically monomorphic pathogen. Infect Genet Evol. 2010;10(1):36-49.
5. Celentano L, Massari M, Paramatti D, Salmaso S, Tozzi A; EUVAC-NET Group. Resurgence of pertussis in Europe. Pediatr Infect Dis J. 2005;24(9):761-65.
6. de Greeff S, Mooi FR, Westerhof A, Verbakel JM, Peeters MF, Heuvelman CJ, et al. Pertussis disease burden in the household: how to protect young infants. Clin Infect Dis. 2010;50(10):1339-45.
7. Bonmarin I, Levy-Bruhl D, Baron S, Guiso N, Njamkepo E, Caro V, et al. Pertussis surveillance in French hospitals: results from a 10 year period. Euro Surveill. 2007;12(1):pii=678. Available from: http://www.eurosurveillance.org/ViewArticle. aspx?ArticleId=678
8. Hellenbrand W, Beier D, Jensen E, Littmann M, Meyer C, Oppermann H, et al. The epidemiology of pertussis in Germany: past and present. BMC Infect Dis. 2009;9:22.
9. Lutsar I, Anca I, Bakir M, Usonis V, Prymula R, Salman N, et al. Epidemiological characteristics of pertussis in Estonia, Lithuania, Romania, the Czech Republic, Poland and Turkey-1945 to 2005. Eur J Pediatr. 2009;168(4):407-15.
10. Torm S, Meriste S, Tamm E, Alusalu S, Järviste A, Lang K. Pertussis outbreak in a basic school in Estonia: description, contributing factors and vaccine effectiveness. Scand J Infect Dis. 2005;37(9):664-68.
11. Grgic-Vitek M, Klavs I, Kraigher A. Re-emergence of pertussis in Slovenia: time to change immunization policy. Vaccine. 2008;26(15):1874-8.
12. Barret A, Ryan A, Breslin A, Cullen L, Murray A, Grogan J, et al. Pertussis outbreak in northwest Ireland, January-June 2010. Euro Surveill. 2010;15(35):pii=19654. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19654
13. Theodoridou M, Hadjipanagis A, Persianis N, Makri S, Hadjichristodoulou C. Pertussis outbreak detected by active surveillance in Cyprus in 2003. Euro Surveill. 2007;12 (5):pii=709. Available from: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=709
14. European surveillance network for vaccine-preventable diseases (EUVAC. NET). Pertussis surveillance report 2010. EUVAC. NET. [Accessed: 19 Jul 2012]. Available from: http://www.euvac.net/graphics/euvac/pdf/pertussis_2010.pdf
15. The European Parliament and the Council of the European Union. Decision number 2119/98/EC of the European Parliament and of the Council of 24 September 1998: setting up a network for the epidemiological surveillance and control of communicable diseases in the community. Official Journal of the European Union. Luxembourg: Publications Office of the European Union. 03.10.1998: L 268. Available from: http://eurlex. europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:1998:268:0 001:0006:EN:PDF
16. Official Journal of the European Union 18.6.2008 L 159/46. Commission Decision of 28 April 2008 amending Decision 2002/253/EC laying down case definitions for reporting communicable diseases to the Community network under Decision No 2119/98/EC of the European Parliament and of the Council (reference number C(2008) 1589) 2008/426/EC. Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2008:159:0046:0090:EN:PDF
17. Crowcroft NS, Booy R, Harrison T, Spicer L, Britto J, Mok Q, et al. Severe and unrecognised: pertussis in UK infants. Arch Dis Child. 2003;88(9):802-6.
18. Versteegh FG, Mooi-Kokenberg EA, Schellekens JF, Roord JJ. Bordetella pertussis and mixed infections. Minerva Pediatr. 2006;58(2):131-37.
19. Reischl U, Lehn N, Sanden GN, Loeffelholz MJ. Real-time PCR assay targeting IS481 of Bordetella pertussis and molecular basis for detecting Bordetella holmesii. J Clin Microbiol. 2001;39(5):1963-6.
20. Register KB, Sanden GN. Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implication for IS481-based detection of Bordetella pertussis. J Clin Microbiol. 2006;44(12):4577-83.
21. Guiso N, Berbers G, Fry NK, He Q, Riffelmann M, Wirsing von König CH et al. What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories. Eur J Clin Microbiol Infect Dis. 2011;30(3):307-12.
22. Riffelmann M, Thiel K, Schmetz J, Wirsing von König CH. Performance of commercial enzyme-linked immunosorbent assays for detection of antibodies to Bordetella pertussis. J Clin Microbiol. 2010;48(12):4459-63.
23. Xing D, Markey K, Newland P, Rigsby P, Hockley J, He Q. EUVAC. NET collaborative study: evaluation and standardisation of serology for diagnosis of pertussis. J Immunol Methods. 2011;372(1-2):137-45.
24. Munoz FM. Pertussis in infants, children, and adolescents: diagnosis, treatment, and prevention. Semin Pediatr Infect Dis. 2006;17(1):14-9.
25. Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, et al. Characterization of reference materials for human antiserum to pertussis antigens proposed by an international collaborative study. Clin Vacc Immunol. 2009;16(3):303-11.
26. Meade BD, Deforest A, Edwards KM, Romani TA, Lynn F, O'Brien CH, et al. Description and evaluation of serologic assays used in a multicenter trial of acellular pertussis vaccines. Pediatrics. 1995,96(3 Pt 2):570-5.
27. Mooi FR, van Loo IH, van Gent M, He Q, Bart MJ, Heuvelman CJ, et al. Bordetella pertussis Strains with Increased Toxin Production Associated with Pertussis Resurgence. Emerg Infect Dis. 2009;15(8):1206-13.
28. Bouchez V, Brun D, Cantinelli T, Dore G, Njamkepo E, Guiso N. First report and detailed characterization of B. pertussis isolates not expressing pertussis toxin or pertactin. Vaccine. 2009;27(43):6034-41.
29. Stefanelli P, Fazio C, Fedele G, Spensieri F, Ausiello CM, Mastrantonio P. A natural pertactin deficient strain of Bordetella pertussis shows improved entry in human monocyte-derived dendritic cells. New Microbiol. 2009;32(2):159-66.
30. Njamkepo E, Brun D, Guiso N. Bordetella holmesii infections in France. Poster number 39. Poster presented at: 9th International Bordetella Symposium; 2010 Sep 30-Oct 3; Baltimore, USA.
31. Fry NK, Duncan J, Pike R, Harrison TG. Emergence of Bordetella holmesii infections in the United Kingdom. Poster number 98. Poster presented at: 9th International Bordetella Symposium; 2010 Sep 30-Oct 3; Baltimore, USA.
32. European Centre for Disease Prevention and Control (ECDC). Core functions of microbiology reference laboratories for communicable diseases. Stockholm:ECDC; Jun 2010. Available from: http://www.ecdc.europa.eu/en/publications/Publications/Forms/ECDC_DispForm.aspx?ID=538
33. Bartkus JM, Juni BA, Ehresmann K, Miller CA, Sanden GN, Cassiday PK, et al. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J Clin Microbiol. 2003;41(3):1167-72.
34. Fry NK, Duncan J, Vaghji L, George RC, Harrison TG. Antimicrobial susceptibility testing of historical and recent clinical isolates of Bordetella pertussis in the United Kingdom using the Etest method. Eur J clin Microbiol Infect Dis. 2010;29(9):1183-5.
35. Elomaa A, He Q, Minh NN, Mertsola J. Pertussis before and after the introduction of acellular pertussis vaccines in Finland. Vaccine. 2009;27(40):5443-9.
36. Lavine JS, Bjørnstad ON, de Blasio BF, Storsaeter J. Shortlived immunity against pertussis, age-specific routes of transmission, and the utility of a teenage booster vaccine. Vaccine. 2012;30(3):544-51.
37. Dalby T, Krogfelt KA, Fry NK, He Q. Bordetella pertussis PCR methods in Europe. A EUVAC. NET/ECDC supported study. Poster number 1392. Poster presented at: 22nd European Congress of Clinical Microbiology and Infectious Diseases; 2012 Mar 31-Apr 3; London, UK.